Facial Angiofibroma Severity Index: A beneficial tool to evaluate the treatment response in the skin of colour.
Hongal AA, Aithal SS, Revathi TN.
Indian J Dermatol Venereol Leprol. 2023 Jan-Frebuary;89(1):130-132. doi: 10.25259/IJDVL_1161_2021.
PMID:36331837
Characterization and management of facial angiofibroma related to tuberous sclerosis complex in the United States: retrospective analysis of the natural history database.
An Bras Dermatol. 2018 Jun;93(3):323-331. doi: 10.1590/abd1806-4841.20186972.
PMID:29924239
Unilateral Facial Angiofibromas.
Basu D, Kumar P, Das A.
Skinmed. 2019 Mar 19;17(1):52-53. eCollection 2019.
PMID:30888949
International consensus recommendations for the identification and treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND).
de Vries PJ, Heunis TM, Vanclooster S, Chambers N, Bissell S, Byars AW, Flinn J, Gipson TT, van Eeghen AM, Waltereit R, Capal JK, Cukier S, Davis PE, Smith C, Kingswood JC, Schoeters E, Srivastava S, Takei M, Gardner-Lubbe S, Kumm AJ, Krueger DA, Sahin M, De Waele L, Jansen AC.